Shelby Derene Reed, PhD

Professor in Population Health Sciences
Professor in Medicine
Associate of the Duke Initiative for Science & Society
Executive Core Faculty Member, Duke-Margolis Center for Health Policy
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Campus mail 300 N Mangum Street, Durham, NC 27701
Phone (919) 668-8991
Email address shelby.reed@duke.edu

Shelby Reed, PhD, RPh is Professor in Population Health Sciences and Medicine at Duke University and Director of the Preference Evaluation Research (PrefER) Group at the Duke Clinical Research Institute.  She also is core faculty and serves on the executive committee at the Duke-Margolis Center for Health Policy. Dr. Reed has 20 years of experience leading multidisciplinary health outcomes research studies. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of diagnostics, drugs and patient-centered interventions. In evaluating health policy issues, she has developed computer models to evaluate the economic impact of trends in clinical trial design, changes in reimbursement policies, a new financing scheme to spur drug development for ultra-rare conditions, and the societal value of alternative approaches to identifying drug safety problems. Over the last several years, her research has increasingly focused on stated-preference studies to evaluate benefit-risk tradeoffs, patient-centered value, and their application in comparative effectiveness research and clinical decision making.  Dr. Reed earned pharmacy and doctoral degrees from the University of Maryland and completed her training in the Pharmaceutical Outcomes Research and Policy Program at the University of Washington. She serves on editorial advisory boards for Value in Health and Health Services Research.  She served as President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in 2017-2018 and is currently Chair of ISPOR's Health Science Policy Council.

 

Areas of expertise: Health Economics, Health Measurement, Stated Preference Research, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of Maryland, College Park, 1998

Publications

Sinha, Saurabh R., Jui-Chen Yang, Matthew J. Wallace, Kiran Grover, F Reed Johnson, and Shelby D. Reed. “Patient preferences pertaining to treatment options for drug-resistant focal epilepsy.” Epilepsy Behav 127 (January 8, 2022): 108529. https://doi.org/10.1016/j.yebeh.2021.108529.

PMID
35016055
Full Text

Reed, Shelby D., Jui-Chen Yang, Timothy Rickert, F Reed Johnson, Juan Marcos Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, et al. “Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.” Circulation. Heart Failure, December 23, 2021, CIRCHEARTFAILURE121008797. https://doi.org/10.1161/circheartfailure.121.008797.

PMID
34937393
Full Text

Chew, Derek S., Yanhong Li, Michel Zeitouni, David J. Whellan, Dalane Kitzman, Robert J. Mentz, Pamela Duncan, et al. “Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.” Jama Cardiology, November 24, 2021. https://doi.org/10.1001/jamacardio.2021.4836.

PMID
34817542
Full Text

Becker, Frauke, Helen A. Dakin, Shelby D. Reed, Yanhong Li, José Leal, Stephanie M. Gustavson, Eric Wittbrodt, Adrian F. Hernandez, Alastair M. Gray, and Rury R. Holman. “Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.” Diabetes Research and Clinical Practice 183 (November 20, 2021): 109152. https://doi.org/10.1016/j.diabres.2021.109152.

PMID
34813910
Full Text

Maxfield, Charles M., J Felipe Montano-Campos, Teresa Chapman, Terry S. Desser, Christopher P. Ho, Nathan C. Hull, Hillary R. Kelly, et al. “Factors Influential in the Selection of Radiology Residents in the Post-Step 1 World: A Discrete Choice Experiment.” J Am Coll Radiol 18, no. 11 (November 2021): 1572–80. https://doi.org/10.1016/j.jacr.2021.07.005.

PMID
34332914
Full Text

Gonzalez, J. M., S. D. Reed, and F. R. Johnson. “Stratified psoriasis treatment plans: why is patient preference information needed?” Br J Dermatol 185, no. 5 (November 2021): 882–83. https://doi.org/10.1111/bjd.20697.

PMID
34463961
Full Text

Sepulveda, Juan Marcos Gonzalez, Jui-Chen Yang, Shelby D. Reed, Ting-Hsuan Lee, Sarah Stothers, Kaiwen Li, Xinyi Ng, Martin Ho, and Telba Irony. “Health Baselines and Stated Preferences: Quantifying the Evolution of Preferences Using LCA.” In Patient Patient Centered Outcomes Research, 14:867–68, 2021.

Scholars@Duke

Mentz, Robert J., David J. Whellan, Gordon R. Reeves, Amy M. Pastva, Pamela Duncan, Bharathi Upadhya, M Benjamin Nelson, et al. “Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction.” Jacc. Heart Failure 9, no. 10 (October 2021): 747–57. https://doi.org/10.1016/j.jchf.2021.05.007.

PMID
34246602
Full Text

Reed, Shelby D., Jui-Chen Yang, Juan Marcos Gonzalez, and F Reed Johnson. “Quantifying Value of Hope.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 24, no. 10 (October 2021): 1511–19. https://doi.org/10.1016/j.jval.2021.04.1284.

PMID
34593175
Full Text

Hung, Anna, Kyung Min Lee, Julie A. Lynch, Yanhong Li, Pradeep Poonnen, Olga V. Efimova, Bradley J. Hintze, et al. “Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer.” Bmc Cancer 21, no. 1 (July 16, 2021): 824. https://doi.org/10.1186/s12885-021-08577-y.

PMID
34271861
Full Text

Pages